Open Access
- 1 January 2011
- journal article
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 9 (1) , 147
Abstract
Ovarian hyperstimulation syndrome (OHSS) still remains a life-threatening complication of in vitro fertilization treatment (IVF), keeping patients and especially those, who previously experienced OHSS, from attempting infertility treatment and childbearing. The recent implementation of four new modalities: the GnRH antagonist protocol, GnRH agonist (GnRHa) triggering of ovulation, blastocyst transfer and embryo/oocyte vitrification, renders feasible the elimination of OHSS in connection with ovarian hyperstimulation for IVF treatment. The proposed current algorithm is based on the number of follicles developed after ovarian stimulation, setting a cut-off level at the development of 18 or more follicles. Further, fulfilling this criterion, the algorithm is based on four decision-making points: the final day of patient work-up, the day of triggering final oocyte maturation, day-1 post oocyte pick-up (OPU) and day-5 post OPU.Keywords
This publication has 26 references indexed in Scilit:
- GnRH agonist for triggering of final oocyte maturation: time for a change of practice?Human Reproduction Update, 2011
- Current progress in oocyte and embryo cryopreservation by slow freezing and vitrificationReproduction, 2011
- The chemokine receptor CXCR4 and its ligand CXCL12 are activated during implantation and placentation in sheepReproductive Biology and Endocrinology, 2011
- Identification of the High-Risk Patient for Ovarian Hyperstimulation SyndromeSeminars in Reproductive Medicine, 2010
- Preventing ovarian hyperstimulation syndrome: guidance for the clinicianFertility and Sterility, 2010
- 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled studyFertility and Sterility, 2010
- Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort studyFertility and Sterility, 2009
- Cryopreservation of human embryos by vitrification or slow freezing: a systematic review and meta-analysisFertility and Sterility, 2008
- The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled studyFertility and Sterility, 2008
- Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilizationReproductive Biology and Endocrinology, 2007